Carl Zeiss Meditec AG (FRA:AFXA)

Market Cap	2.45B -41.8%
Revenue (ttm)	2.23B +7.8%
Net Income	141.21M -21.0%
EPS	1.61 -19.8%
Shares Out	n/a
PE Ratio	17.36
Forward PE	16.37
Dividend	0.38 (1.25%)
Ex-Dividend Date	Mar 28, 2025

Volume	n/a
Average Volume	50
Open	27.20
Previous Close	28.00
Day's Range	27.20 - 27.20
52-Week Range	26.80 - 70.00
Beta	n/a
RSI	27.25
Earnings Date	Feb 12, 2026

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and p...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1846
• Employees: 5,784
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AFXA

Financial Performance

In 2025, Carl Zeiss Meditec AG's revenue was 2.23 billion, an increase of 7.82% compared to the previous year's 2.07 billion. Earnings were 141.21 million, a decrease of -20.99%.